Distribution of information regarding the identified EbA measures among the four plan components.</p
Distribution of baseline characteristics overall and across outcome categories.</p
The distribution of blood pressure, plasma glucose and blood lipid levels among different BMI and WC...
<p>Distribution of the study sample by country, facility type and health insurance accreditation sta...
Distribution of mentions of the identified EbA measures across plan components.</p
Distribution of information relevant to the plan components in the sample of plans and policies.</p
Distribution of quality scores in plan components for identified EbA measures.</p
Distribution of quality scores in plans and policies for identified EbA measures.</p
The variation in breadth score indicator value across EbA measures in any one of the plan components...
Distribution of demographic, clinical and treatment characteristics by CD4 count.</p
Distribution of surrogate measures for insulin resistance at baseline examination.</p
<p>Distribution of adherence by unannounced pill count and electronic monitoring.</p
Description of variables and parameters used to estimate distribution of indirect and direct doses.<...
Distribution of the number of ANC components or items received by the mothers.</p
Distribution of the experimental groups according to treatment received, ethanasia times, and treatm...
Distribution of baseline characteristics between outcome categories, and their differences.</p
Distribution of baseline characteristics overall and across outcome categories.</p
The distribution of blood pressure, plasma glucose and blood lipid levels among different BMI and WC...
<p>Distribution of the study sample by country, facility type and health insurance accreditation sta...
Distribution of mentions of the identified EbA measures across plan components.</p
Distribution of information relevant to the plan components in the sample of plans and policies.</p
Distribution of quality scores in plan components for identified EbA measures.</p
Distribution of quality scores in plans and policies for identified EbA measures.</p
The variation in breadth score indicator value across EbA measures in any one of the plan components...
Distribution of demographic, clinical and treatment characteristics by CD4 count.</p
Distribution of surrogate measures for insulin resistance at baseline examination.</p
<p>Distribution of adherence by unannounced pill count and electronic monitoring.</p
Description of variables and parameters used to estimate distribution of indirect and direct doses.<...
Distribution of the number of ANC components or items received by the mothers.</p
Distribution of the experimental groups according to treatment received, ethanasia times, and treatm...
Distribution of baseline characteristics between outcome categories, and their differences.</p
Distribution of baseline characteristics overall and across outcome categories.</p
The distribution of blood pressure, plasma glucose and blood lipid levels among different BMI and WC...
<p>Distribution of the study sample by country, facility type and health insurance accreditation sta...
DOI
Add to ORKG